Long-term survival after systemic chemotherapy, chemoradiotherapy, and maintenance therapy for an older adult patient with recurrent pancreatic acinar cell carcinoma
Clinical Journal of Gastroenterology · 2024
DOI: 10.1007/s12328-024-01981-4 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Journal of Gastroenterology, 2024. Verfasst von Makiko Urabe und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-Ku, Osaka, 541-8567, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Carcinoma, Acinar Cell, Chemoradiotherapy, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Pancreatic acinar cell carcinoma (PACC) is a rare cancer with no specific treatment. The treatment and chemotherapy for PACC are selected according to pancreatic ductal adenocarcinoma (PDAC). Herein, we describe a recurrent PACC case of an older adult patient. The patient was treated with systemic chemotherapy, chemoradiotherapy, and maintenance therapy based on the pathologic germline BRCA2 variant, resulting in long-term survival. The pathogenic BRCA variant is detected more frequently in patients with PACC than in those with PDAC. The BRCA variant significantly impacts treatment selection and prognosis; therefore, early genomic analysis is recommended when treating PACC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-Ku, Osaka, 541-8567, Japan.
- Department of Hepatobiliary and Pancreatic Oncology, Osaka International Cancer Institute, 3-1-69 Otemae, Chuo-Ku, Osaka, 541-8567, Japan. ikezawa-ke@oici.jp.
- Department of Gastroenterological Surgery, Osaka International Cancer Institute, Osaka, Japan.
Zitieren
APA
Urabe, M., Ikezawa, K., Kozumi, K., Kai, Y., Takada, R., Mukai, K., Nakabori, T., Uehara, H., Akita, H., & Ohkawa, K. (2024). Long-term survival after systemic chemotherapy, chemoradiotherapy, and maintenance therapy for an older adult patient with recurrent pancreatic acinar cell carcinoma. Clinical Journal of Gastroenterology. https://doi.org/10.1007/s12328-024-01981-4
Vancouver
Urabe M, Ikezawa K, Kozumi K, Kai Y, Takada R, Mukai K, et al. Long-term survival after systemic chemotherapy, chemoradiotherapy, and maintenance therapy for an older adult patient with recurrent pancreatic acinar cell carcinoma. Clinical Journal of Gastroenterology. 2024. doi:10.1007/s12328-024-01981-4
BibTeX
@article{Urabe2024,
author = {Urabe, Makiko and Ikezawa, Kenji and Kozumi, Kazuhiro and Kai, Yugo and Takada, Ryoji and Mukai, Kaori and Nakabori, Tasuku and Uehara, Hiroyuki and Akita, Hirofumi and Ohkawa, Kazuyoshi},
title = {Long-term survival after systemic chemotherapy, chemoradiotherapy, and maintenance therapy for an older adult patient with recurrent pancreatic acinar cell carcinoma},
journal = {Clinical Journal of Gastroenterology},
year = {2024},
doi = {10.1007/s12328-024-01981-4}
}
EUVIMED